{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T14:54:57Z","timestamp":1766588097600},"publisher-location":"Chichester, UK","reference-count":88,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd000024.pub2","type":"reference-entry","created":{"date-parts":[[2004,7,21]],"date-time":"2004-07-21T07:08:53Z","timestamp":1090393733000},"source":"Crossref","is-referenced-by-count":51,"title":["Anticoagulants for acute ischaemic stroke"],"prefix":"10.1002","author":[{"given":"G","family":"Gubitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Sandercock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Counsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,7,19]]},"reference":[{"key":"10.1002\/14651858.CD000024.pub2-BIB1|cit1","first-page":"121","article-title":"Mesoglycan in the treatment of acute cerebral infarction","volume":"59","author":"Cazzato","year":"1989","journal-title":"Rivista di Neurologia"},{"key":"10.1002\/14651858.CD000024.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/01.STR.14.5.668","article-title":"Immediate anticoagulation of embolic stroke: a randomized trial. The Cerebral Embolism Study Group","volume":"14","author":"Hakim","year":"1983","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000024.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.STR.14.6.893","article-title":"Sequential computerized tomographic appearances of strokes","volume":"14","author":"Hakim","year":"1983","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000024.pub2-BIB4|cit4","first-page":"21","article-title":"Clinical trial of low-dose heparin for the prevention of stroke progression (abstract)","volume":"Suppl III","author":"Duke","year":"1980","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD000024.pub2-BIB5|cit5","first-page":"399","article-title":"Clinical trial of low-dose subcutaneous heparin for the prevention of stroke progression: natural history of acute partial stroke and stroke-in-evolution","volume-title":"Cerebrovascular Disease","author":"Duke","year":"1983"},{"key":"10.1002\/14651858.CD000024.pub2-BIB6|cit6","first-page":"782","article-title":"Heparin in acute partial stable stroke (abstract)","volume":"106","author":"Duke","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000024.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-105-6-825","article-title":"Intravenous heparin for the prevention of stroke progression in acute partial stable stroke","volume":"105","author":"Duke","year":"1986","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000024.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-106-5-781","article-title":"Heparin in acute partial stable stroke (letter)","volume":"106","author":"Easton","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000024.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-106-5-781","article-title":"Heparin in acute partial stable stroke (letter)","volume":"106","author":"Loeliger","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000024.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0248-8663(05)80622-8","article-title":"Prevention of deep venous thrombosis of the leg by a very low molecular weight heparin fraction (CY 222) in patients with hemiplegia following cerebral infarction: a randomized pilot study (30 patients)","volume":"11","author":"Elias","year":"1990","journal-title":"Revue de Medecine Interne"},{"key":"10.1002\/14651858.CD000024.pub2-BIB11|cit11","first-page":"253","article-title":"Fraxiparin in stroke study (abstract)","volume":"25","author":"Kay","year":"1994","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000024.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJM199512143332402","article-title":"Low-molecular-weight heparin for the treatment of acute ischemic stroke","volume":"333","author":"Kay","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"suppl 4","key":"10.1002\/14651858.CD000024.pub2-BIB13|cit13","first-page":"19","article-title":"Fraxiparine in Ischaemic Stroke Study (FISS bis) (abstract)","volume":"8","author":"Hommel","year":"1998","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000024.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000024.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jnnp.60.4.371","article-title":"Study design of the International Stroke Trial (IST), baseline data, and outcome in 984 randomised patients in the pilot study","volume":"60","year":"1996","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD000024.pub2-BIB16|cit16","first-page":"234","article-title":"A randomized trial of Fraxiparine in acute ischaemic stroke (abstract)","volume":"5","author":"Kwiecinski","year":"1995","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000024.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(60)90885-0","article-title":"Anticoagulant therapy in acute cerebrovascular accidents: a controlled trial","volume":"1","author":"Marshall","year":"1960","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000024.pub2-BIB18|cit18","first-page":"547","article-title":"Anticoagulant therapy in cerebrovascular disease","author":"Marshall","year":"1960","journal-title":"Proceedings of the Royal Society of Medicine"},{"key":"10.1002\/14651858.CD000024.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0140-6736(77)90728-0","article-title":"Low dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke","volume":"ii","author":"McCarthy","year":"1977","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000024.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ageing\/15.2.84","article-title":"Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke","volume":"15","author":"McCarthy","year":"1986","journal-title":"Age and Ageing"},{"key":"10.1002\/14651858.CD000024.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1212\/WNL.12.12.823","article-title":"Anticoagulant therapy in cerebral infarction. Report on co-operative study","volume":"12","author":"Baker","year":"1962","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000024.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1212\/WNL.11.4_Part_2.119","article-title":"Anticoagulant therapy in cerebral thrombosis and cerebral embolism. A national cooperative study, interim report","volume":"11","author":"Miller Fisher","year":"1961","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000024.pub2-BIB24|cit23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00002060-199112000-00006","article-title":"Deep vein thrombosis in rehabilitating stroke patients. Incidence, risk factors and prophylaxis","volume":"70","author":"Desmukh","year":"1991","journal-title":"Am J Phys Med & Rehab"},{"key":"10.1002\/14651858.CD000024.pub2-BIB23|cit24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0003-9993(95)80657-1","article-title":"Deep vein thrombosis: prevention in stroke patients during rehabilitation","volume":"76","author":"Pambianco","year":"1995","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"volume-title":"Thromboses veineuses des membres inferieurs et embolies pulmonaires au cours des accidents vasculaires cerebraux. A propos d'un essai comparitif de traitement preventif (These pour le doctorat d'etat en medecine)","year":"1981","author":"Pince","key":"10.1002\/14651858.CD000024.pub2-BIB25|cit25"},{"key":"10.1002\/14651858.CD000024.pub2-BIB26|cit26","first-page":"117","article-title":"Deep venous thrombosis prophylaxis with a LMW heparin (KABI 2165) in stroke patients (abstract)","volume":"58","author":"Prins","year":"1987","journal-title":"Thromb Haemost"},{"key":"10.1002\/14651858.CD000024.pub2-BIB27|cit27","first-page":"245","article-title":"Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165\/Fragmin) in stroke patients","volume":"19","author":"Prins","year":"1989","journal-title":"Haemostasis"},{"key":"10.1002\/14651858.CD000024.pub2-BIB28|cit28","first-page":"392","article-title":"Venous thromboembolic complications in acute thrombotic stroke. Progress report from a randomized trial (abstract)","volume":"76","author":"Sandset","year":"1987","journal-title":"Acta Neurol Scand"},{"issue":"Suppl","key":"10.1002\/14651858.CD000024.pub2-BIB29|cit29","first-page":"25","article-title":"A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke","volume":"16","author":"Sandset","year":"1990","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1002\/14651858.CD000024.pub2-BIB30|cit30","first-page":"3047","article-title":"Therapeutic effect of thrombin inhibitor MD-805 in acute phase of cerebral thrombosis - Phase II double-blinded clinical trial (English translation)","volume":"63","author":"Tazaki","year":"1986","journal-title":"Rinsho to Kenkyu (Japanese Journal of Clinical and Experimental Medicine)"},{"key":"10.1002\/14651858.CD000024.pub2-BIB31|cit31","first-page":"887","article-title":"Clinical usefulness of thrombin inhibitor MD-805 in acute phase of cerebral thrombosis - double blinded comparative study using placebo as a control (English translation)","volume":"161","author":"Tazaki","year":"1992","journal-title":"Igaku no Ayumi (Journal of Clinical and Experimental Medicine)"},{"key":"10.1002\/14651858.CD000024.pub2-BIB32|cit32","first-page":"545","article-title":"Trial of Org 10172 in Acute Stroke Treatment (TOAST) (abstract)","volume":"25","author":"Adams","year":"1994","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000024.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.279.16.1265","article-title":"Low molecular weight heparinoid, ORG 10172 (Danaparoid), and outcome after acute ischaemic stroke","volume":"279","year":"1998","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000024.pub2-BIB34|cit34","first-page":"85","article-title":"Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke","volume":"543","author":"Turpie","year":"1988","journal-title":"Acta Chirurgica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD000024.pub2-BIB36|cit35","first-page":"123","article-title":"A double-blind randomized trial of Org 10172 low molecular weight heparinoid in the prevention of deep venous thrombosis in patients with thrombotic stroke (abstract)","volume":"58","author":"Turpie","year":"1987","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD000024.pub2-BIB35|cit36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(87)90173-5","article-title":"Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke","volume":"1","author":"Turpie","year":"1987","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000024.pub2-BIB37|cit37","unstructured":"Vissinger H Husted S Trial of tinzaparin versus placebo in ischaemic stroke Unpublished work"},{"key":"10.1002\/14651858.CD000024.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/jnnp.38.7.642","article-title":"Trial of long-term anticoagulant therapy in the treatment of small stroke associated with a normal carotid angiogram","volume":"38","author":"Bradshaw","year":"1975","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD000024.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/bmj.2.5244.70","article-title":"Anticoagulant treatment in progressing stroke","volume":"II","author":"Carter","year":"1961","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000024.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1212\/WNL.11.7.601","article-title":"Use of anticoagulants in patients with progressive cerebral infarction","volume":"11","author":"Carter","year":"1961","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000024.pub2-BIB41|cit41","unstructured":"Oczkowski WJ A randomised trial of fixed low dose warfarin in the prevention of deep vein thrombosis in patients undergoing rehabilitation after stroke (Cou 9116) Unpublished protocol"},{"key":"10.1002\/14651858.CD000024.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1055\/s-2008-1070492","article-title":"Prevention of venous thrombosis in recent ischaemic cerebrovascular accident: double-blind study with heparin-dihydroergotamine (author's translation)","volume":"106","author":"Czechanowski","year":"1981","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD000024.pub2-BIB43|cit43","first-page":"159","article-title":"Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial","volume":"16","author":"Dahan","year":"1986","journal-title":"Haemostasis"},{"key":"10.1002\/14651858.CD000024.pub2-BIB44|cit44","unstructured":"Dehen H on behalf of Laboratoire Houde Double blind placebo controlled study of dermatan sulphate in acute middle cerebral artery infarct Unpublished work"},{"issue":"Suppl 438","key":"10.1002\/14651858.CD000024.pub2-BIB45|cit45","first-page":"7","article-title":"Long term anticoagulant therapy in patients with cerebral infarction: a controlled clinical study","volume":"178","author":"Enger","year":"1965","journal-title":"Acta Medica Scandinavica"},{"key":"10.1002\/14651858.CD000024.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0404.1983.tb04823.x","article-title":"Evaluation of anticoagulants in patients with cerebral infarction with slight to moderate neurological deficit","volume":"68","author":"Eriksson","year":"1983","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD000024.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-0404.1980.tb01498.x","article-title":"Effects of low-dose subcutaneous heparin on the occurrence of deep vein thrombosis in patients with ischemic stroke","volume":"61","author":"Gelmers","year":"1980","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD000024.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00001721-199507000-00008","article-title":"Thrombin inhibition in the acute phase of ischaemic stroke using argatroban","volume":"6","author":"Kario","year":"1995","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"10.1002\/14651858.CD000024.pub2-BIB49|cit49","first-page":"268","article-title":"Therapeutic efficacy of urokinase and heparin in acute ischemic stroke (abstract)","volume":"25","author":"Lee","year":"1994","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000024.pub2-BIB50|cit50","unstructured":"McCarthy S McWalter R Durkin CJ Hallawi AH Magnani HN Pearson J Org 10172 for the prophylaxis of deep venous thrombosis in the legs (A protocol to establish the efficacy and safety of once or twice daily subcutaneous Org 10172 injections versus placebo in three groups of 60 non-haemorrhagic stroke victims) Unpublished Protocol"},{"key":"10.1002\/14651858.CD000024.pub2-BIB52|cit51","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7326\/0003-4819-55-3-358","article-title":"A long-term study of cerebral vascular disease","volume":"55","author":"Groch","year":"1961","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000024.pub2-BIB51|cit52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/01.CIR.20.2.215","article-title":"A cooperative study of cerebrovascular disease","volume":"20","author":"McDevitt","year":"1959","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD000024.pub2-BIB54|cit53","first-page":"185","article-title":"Treatment of the completed stroke with long-term anticoagulant: six and one-half years experience","volume-title":"Cerebral Vascular Diseases","author":"McDowell","year":"1965"},{"key":"10.1002\/14651858.CD000024.pub2-BIB53|cit54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archneur.1963.00460020109009","article-title":"Anticoagulant therapy: five years' experience with the patient with an established cerebrovascular accident","volume":"8","author":"McDowell","year":"1963","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD000024.pub2-BIB55|cit55","unstructured":"Rosin A Abramovitz Z Preventing deep venous thrombosis following acute strokes Unpublished protocol"},{"key":"10.1002\/14651858.CD000024.pub2-BIB56|cit56","unstructured":"Stiekema JCJ Egberts J Voerman J An open, randomised, rising dose, pilot two-centre study of Org 10172 administered for the purpose of deep vein thrombosis prophylaxis in patients with a non-haemorrhagic stroke on recent onset Organon International, 1988 (SDG Release Report 2244)"},{"key":"10.1002\/14651858.CD000024.pub2-BIB57|cit57","first-page":"233","article-title":"Cerebral apoplexy: a clinical, radiological, electroencephalographic and pathological study with special reference to the prognosis of cerebral infarction and the result of long-term anticoagulant therapy","volume":"11","author":"Thygesen","year":"1964","journal-title":"Danish Medical Bulletin"},{"key":"10.1002\/14651858.CD000024.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3995\/jstroke.11.500","article-title":"Effects of urokinase and heparin on haemorrhagic infarction, recanalisation, recurrence - analysis of 111 cases with middle cerebral artery occlusion on a prospective controlled trial [author's translation]","volume":"11","author":"Tsuchiya","year":"1989","journal-title":"Japanese Journal of Stroke"},{"key":"10.1002\/14651858.CD000024.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3995\/jstroke.12.177","article-title":"A study on clinical effects of urokinase and heparin for acute lacunar infarcts in a prospective controlled trial [author's translation]","volume":"11","author":"Tsuchiya","year":"1990","journal-title":"Japanese Journal of Stroke"},{"key":"10.1002\/14651858.CD000024.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.11.4_Part_2.132","article-title":"An evaluation of anticoagulant therapy in the treatment of cerebrovascular disease. Report of the Veterans Administration Cooperative Study of Atherosclerosis, Neurology Section","volume":"11","author":"Baker","year":"1961","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD000024.pub2-BIB61|cit61","first-page":"246","article-title":"Results of ARGIS-1: argatroban injection in acute ischemic stroke","volume":"34","author":"LaMonte","year":"2003","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000024.pub2-BIB62|cit62","first-page":"168","article-title":"Improvement of outcome in patients with acute ischaemic stroke treated with fragmin","volume":"30 (Suppl 2)","author":"Dan","year":"2000","journal-title":"Haemostasis"},{"key":"10.1002\/14651858.CD000024.pub2-BIB63|cit63","unstructured":"American Heart Association Heart and Stroke Disease Statistics - 2003 update www.americanheart.org"},{"key":"10.1002\/14651858.CD000024.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/01.STR.0000018081.33541.E3","article-title":"Use of intravenous heparin by North American neurologists: does the data matter?","volume":"33","author":"Al-Sadat","year":"2002","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000024.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/bmj.313.7055.486","article-title":"Interaction 1: heterogeneity of effects","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000024.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000024.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1161\/01.STR.0000028456.18614.93","article-title":"Anticoagulants and antiplatelet agents in acute ischemic stroke","volume":"33","author":"Coull","year":"2002","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000024.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000024.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/jnnp.53.1.16","article-title":"A prospective study of acute cerebrovascular disease in the community: The Oxfordshire Community Stroke Project 1981-1986. 2. Incidence, case fatality and overall outcome at one year of cerebral infarction, primary intracerebral haemorrhage and subarachnoid haemorrhage","volume":"53","author":"Bamford","year":"1990","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD000024.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/01.STR.26.4.541","article-title":"Monitoring stroke: an international challenge","volume":"26","author":"Bonita","year":"1995","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000024.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.STR.29.2.415","article-title":"The Greater Cincinnati\/Northern Kentucky Stroke Study","volume":"29","author":"Broderick","year":"1998","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000024.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1056\/NEJM198805053181805","article-title":"Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin","volume":"318","author":"Collins","year":"1988","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD000024.pub2-BIB73|cit73","article-title":"Low molecular weight heparin or heparinoids versus standard unfractionated heparin for acute ischemic stroke","author":"Counsell","year":"2003","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD000024.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.STR.27.3.415","article-title":"Complications after acute stroke","volume":"27","author":"Davenport","year":"1996","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000024.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000024.pub2-BIB76|cit76","unstructured":"European Union Stroke Initiative website Recommendations for stroke management: acute treatment of ischemic stroke www.eusi-stroke.com\/recommendations\/rc_acutetreatment1.shtml 2003"},{"key":"10.1002\/14651858.CD000024.pub2-BIB77|cit77","unstructured":"Gubitz G Sandercock P Signorini D Different doses of anticoagulant for acute ischaemic stroke (protocol for Cochrane Review) In preparation"},{"key":"10.1002\/14651858.CD000024.pub2-BIB78|cit78","first-page":"312","article-title":"Management of stroke among academic medical centers (abstract)","volume":"29","author":"Brass","year":"1998","journal-title":"Stroke"},{"volume-title":"Are very large trials of promising treatments for acute stroke feasible?","year":"1993","author":"Lindley","key":"10.1002\/14651858.CD000024.pub2-BIB79|cit79"},{"issue":"1","key":"10.1002\/14651858.CD000024.pub2-BIB80|cit80","article-title":"Fibrinogen depleting agents for acute ischaemic stroke (Cochrane Review)","author":"Liu","year":"2003","journal-title":"The Cochrane Library"},{"issue":"4","key":"10.1002\/14651858.CD000024.pub2-BIB81|cit81","article-title":"Antithrombotic drugs for carotid artery dissection","author":"Lyrer","year":"2003","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD000024.pub2-BIB82|cit82","unstructured":"The Royal College of Physicians (UK) National Electronic Library for Health - Stroke Website: http:\/\/www.rcplondon.ac.uk\/uk\/pubs\/books\/stroke\/ceeu_stroke_clinical07.htm"},{"key":"10.1002\/14651858.CD000024.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.273.5.408","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000024.pub2-BIB84|cit84","unstructured":"Scottish Intercollegiate Guideline Network Secretariat Management of patients with stroke: 1. Assessment, investigation, immediate management and secondary prevention www.sign.ac.uk"},{"issue":"4","key":"10.1002\/14651858.CD000024.pub2-BIB85|cit85","article-title":"Anticoagulation for cerebral sinus thrombosis","author":"Stam","year":"2003","journal-title":"The Cochrane Library"},{"issue":"1","key":"10.1002\/14651858.CD000024.pub2-BIB86|cit86","article-title":"Thrombolysis for acute ischaemic stroke","author":"Wardlaw","year":"2003","journal-title":"The Cochrane Library"},{"volume-title":"World Development Report: Investing in Health","year":"1993","key":"10.1002\/14651858.CD000024.pub2-BIB87|cit87"},{"key":"10.1002\/14651858.CD000024.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/jnnp.56.1.17","article-title":"Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials","volume":"56","author":"Sandercock","year":"1993","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000024.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T20:53:20Z","timestamp":1628542400000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000024.pub2"}},"subtitle":[],"editor":[{"given":"Peter","family":"Sandercock","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2004,7,19]]},"references-count":88,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000024.pub2","relation":{},"subject":[],"published":{"date-parts":[[2004,7,19]]}}}